"这一切都有关联:"一种混合方法研究失眠,耻辱和歧视在服用阿片类药物使用障碍药物的人群中
Uzoji Nwanaji-Enwerem1, Lois S Sadler1, Meghan O'Connell2
1Yale School of Nursing, Orange, Connecticut, USA; Yale School of Public Health, New Haven, Connecticut, USA.
Sleep health
|November 18, 2023
概括
像耻辱和歧视这样的社会压力因素与阿片类药物使用障碍 (OUD) 患者的失眠有关. 负面情绪和反会使这个人群的睡眠状况恶化.
科学领域:
- 睡眠医学 睡眠医学
- 成精神病学成精神病学
- 健康的社会决定因素
背景情况:
- 失眠在患有阿片类药物使用障碍 (OUD) 的人群中非常普遍,特别是那些接受药物辅助治疗的人群.
- 关于社会压力因素 (如耻辱和歧视) 对这一弱势群体睡眠质量的影响的研究有限.
- 了解这些心理社会因素对于制定有针对性的干预措施至关重要.
研究的目的:
- 调查与阿片类药物使用障碍 (OUD) 相关的耻辱和与失眠严重程度的交叉歧视之间的联系.
- 探索服用OUD药物的个人关于耻辱感,歧视和他们的睡眠生活经验.
- 为了确定在这个人口群体中导致睡眠障碍的心理社会因素.
主要方法:
- 使用定量调查 (n=120) 和定性访谈 (n=25) 的融合混合方法设计.
- 经过验证的尺度衡量了阿片类药物污名,交叉歧视和失眠严重程度.
- 数据整合允许全面了解心理社会压力因素与睡眠之间的相互作用.
主要成果:
- 定量分析显示,截面歧视,疼痛,感知压力,心理困扰和失眠严重程度之间存在正相关性.
- 定性发现确定了四个关键主题,将耻辱和歧视的经历与消极情绪和反省联系起来,参与者与睡眠不足有关.
- 整合了定量和定性数据,突出了关于压力因素对睡眠影响的一致和分歧的发现.
结论:
- 与阿片类药物使用障碍 (OUD) 相关的耻辱,歧视,身体症状和心理困扰显著导致失眠.
- 不适应的应对机制,包括反和负面情绪状态,是改善OUD患者睡眠结果的关键目标.
- 未来的研究应该专注于解决这些心理社会因素的干预措施,以提高这一群体的睡眠质量.
更多相关视频
04:59Heat-sensitive Moxibustion as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Insomnia
Published on: May 30, 2025
278
04:34Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
1.1K
相关概念视频
Blind Procedures
10.6K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
10.6K
Substance Use Disorders Affecting Sleep
173
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
173
Sedatives and Hypnotics Drugs: Miscellaneous Agents
180
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
180
Management of Insomnia
257
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
257
Insomnia
87
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
87
CNS Depressants: Barbiturates and Benzodiazepines
282
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
282
